Company Filing History:
Years Active: 1981-1990
Title: David A Owen: Innovator in Anxiolytic and Parkinson's Disease Treatments
Introduction
David A Owen is a notable inventor based in Welwyn Garden City, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of anxiety and Parkinson's disease. With a total of 6 patents to his name, Owen's work has the potential to impact many lives.
Latest Patents
Owen's latest patents focus on producing anxiolytic activity and treating depression with 3(H)-indolones. One of his key inventions involves the use of certain indolone derivatives, specifically 4-(2-di-n-propyl-aminoethyl)-2-(3H)-indolone, in methods for treating Parkinson's disease. This innovative approach highlights the therapeutic potential of these compounds in addressing neurological disorders.
Career Highlights
David A Owen is associated with Smith Kline & French Laboratories Limited, where he has been instrumental in advancing research and development in his field. His work has garnered attention for its relevance and applicability in modern medicine.
Collaborations
Owen has collaborated with esteemed colleagues such as Charon R Ganellin and Robert John Ife. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his inventions.
Conclusion
David A Owen's contributions to the field of pharmaceuticals, particularly in the treatment of anxiety and Parkinson's disease, underscore his role as an influential inventor. His innovative work continues to pave the way for advancements in medical treatments.